Stocks
Central Pharma declares its dividends
Central Pharma has declared no dividend for the financial year ended June 30, 2022, after reviewing and approving the financial report of the current financial year at the meeting.
According to the financial report of the completed financial year, the earnings per share (EPS) of the company loss by 57 paisa.
The company’s NAV per share (NAVPS) at the end of June 30, 2022, stood at Tk 5.96 paisa, the firm will hold the Annual General Meeting (AGM) on December 29 to approve this dividend. The record date for this has been fixed on November 24.
/NR
One of the listed companies, Global Heavy Chemicals Limited discloses its financial reports for the third quarter, (January – March 24).
The company’s earnings per share (EPS) was loss Tk 0.18 paisa in Q3 of the current financial year (January – March 24). EPS was loss Tk 0.53 paisa during the same period last year. NAV per share was Tk. 42.11 as on March 31, 2024.
One of the listed companies, Navana Pharmaceuticals PLC discloses its financial reports for the third quarter, (January – March 24).
The company’s earnings per share (EPS) was Tk 1.00 paisa in Q3 of the current financial year (January – March 24). EPS was Tk 1.09 paisa during the same period last year. NAV per share was Tk. 42.11 as on March 31, 2024.
One of the listed companies, Northern Islami Insurance Limited discloses its financial reports for the first quarter, (January – March 24).
The company’s earnings per share (EPS) was Tk 0.70 paisa in Q1 of the current financial year (January – March 24). EPS was Tk 0.69 paisa during the same period last year. NAV per share was loss Tk. 24.69 as of March 31, 2024
